exome sequencing

Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration

Blueprint Genetics to Analyze Biobank Samples for Rare Diseases in New Finnish Study

Centogene Q2 Revenues Continue to Benefit From COVID-19 Testing as Core Business Starts to Recover

ACMG Recommends Sequencing as Test for Children With Intellectual Disability, Congenital Anomalies

Helix Raises $50M in Series C Financing

ACMG Updates Gene List for Labs Reporting Clinical Sequencing Secondary Findings

Rare Disease Screening Firm 3billion Closes $13M Series C Financing

Twist Bioscience, Victorian Clinical Genetic Services Develop Diagnostic Exome Assay

Natera, Personalis Team up for Cancer Treatment Monitoring, MRD Testing

Helix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk Test

Parents, Physicians View Genome Sequencing as Useful for Managing Care of Seriously Ill Infants

ESHG, ACMG Differ Starkly in Recommendations for Reporting Secondary Findings From Genomic Tests

Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders

JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio